Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

20112,079 citationsJournal Articlebronze Open Access

Authors

Marc Ychou · CHU Dijon Bourgogne

Valérie Boige · CHU Dijon Bourgogne

Jean‐Pierre Pignon · CHU Dijon Bourgogne

Thierry Conroy · CHU Dijon Bourgogne

Olivier Bouché · CHU Dijon Bourgogne

G. Lebreton · CHU Dijon Bourgogne

Muriel Ducourtieux ·

Abstract

In patients with resectable adenocarcinoma of the lower esophagus, GEJ, or stomach, perioperative chemotherapy using fluorouracil plus cisplatin significantly increased the curative resection rate, disease-free survival, and OS.

Topics & Keywords

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Gastrointestinal Tumor Research and Treatment

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Journal of Clinical Oncology

Volume 29, Issue 13, pp. 1715-1721

DOI: 10.1200/jco.2010.33.0597

Field-Weighted Citation Impact: 97.73